Posted by Michael Wonder on 13 Sep 2022
BWXT Medical submits Tc 99m generator new drug application to FDA
13 September 2022 - Company highlights growing nuclear medicine product portfolio and future opportunities in therapeutic radioisotopes.
BWX Technologies announced today that subsidiary BWXT Medical has submitted a new drug application to the US FDA to request approval of its technetium 99m (Tc 99m) generator for diagnostic imaging.
